top of page
< Back

Aprepitant


Mechanism of action:

Aprepitant is a selective neurokinin-1 (NK1) receptor antagonist. It works by blocking neurokinin-1 receptors in the central and peripheral nervous systems, thereby preventing substance P from binding to these receptors.

Reference(s):

1. Dando TM et al. (2004). Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs. 


2. Navari RM et al. (2004). Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 


3. Sanchez RI et al. (2004). Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant. Drug Metab Dispos.

bottom of page